Clinical Trial Update: Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine [Phase 1]

View source ↗

Summary

Long-term follow-up data from Phase 1 studies evaluating GlaxoSmithKline's HIV vaccine are reported; the trials have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome

Drugs mentioned

• GSK HIV vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: AIDS | Phase 1 | Status: COMPLETED